Thermo Fisher Scientific Inc. — Company profile
Healthcare · Diagnostics & Research · United States
Last price 697 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 258.25B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Details
| Name | Thermo Fisher Scientific Inc. |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Employees | 125000 |
| Founded | 1956 |
| Ceo | Marc Casper |
| Country | United States |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US8835561023 |
| Cusip | 883556102 |
| Cik | 0000097745 |
| Sic | 3829 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Marc N. Casper | Chairman and Chief Executive Officer |
| Gianluca Pettiti | President, Chief Operating Officer and President of Products and Technologies |
| James R. Meyer | Senior Vice President and Chief Financial Officer |
| Joseph R. Holmes | Vice President and Chief Accounting Officer |
| Ryan J. Snyder | Senior Vice President and Chief Information Officer |
| Dr. Karen E. Nelson Ph.D. | Chief Scientific Officer |
| Rafael Tejada | Vice President of Investor Relations |
| Thomas Bailey Shropshire Jr. | Senior Vice President and General Counsel |
| Sandy B. Pound | Vice President and Chief Communications Officer |
| Alan J. Malus | Senior Vice President of Strategy and Corporate Development |
Contact
| Address | 168 Third Avenue, Waltham, Massachusetts 02451, United States |
| Phone | 781 622 1000 |
| Website | https://www.thermofisher.com |